Bioventix (BVXP)

-

A stock that I have been following for a while now is growth AIM small-cap stock Bioventix, who specialise in sheep antibodies and currently has a market cap of £191 million. The shares currently trade at over £38, which appears expensive at first glance. However, the company has performed extremely well over the last 3 and a half years since 2016, producing a return of 197% for investors.

To better understand the stock’s investment potential, investors need to look deeper into the company, researching areas such as its current business model and current financial situation. This will provide a clearer understanding as to whether the stock will provide future returns. 


BIOTECHNOLOGY

The firm operates in the biotechnology space, specialising in antibodies produced from sheep for use in diagnostic applications, for example, in the testing of drugs of abuse. Some of its top clients include Siemens and Philips, which supply testing machines to hospitals. 

These companies highlight the already strong client list that Bioventix has, something that I always try and look for when investing in small companies to gauge an idea of their current success. It’s important to understand who is buying the product in order to assess its value in the current market, and hence big names such as Philips provide a good indication for demand.

Due to the niche in which the firm operates, there are high barriers to entry for firms wanting to join the market place. For example, the required knowledge is both hard to find and therefore, expensive to hire. With such high barriers to entry, this prevents profits being competed away by new entrants to the market and in turn ensures Bioventix can continue to produce superior margins. 

VALUATION METRICS

Taking a look at the valuation metrics of the business, operating margin has been steadily growing for the last 4 years, with an operating margin of 85% in 2018, up from 65% in 2014. This is relatively high and links back to the ability to produce high margins on products due to markets being less competitive as a result of high barriers to entry. 

Further supporting the growth prospects of the business, there is a steady increase in net cash flow from operating activities, which reached £5.9 million in 2018. This indicates the company not only has the expertise in terms of their specific sector but also a competent management team in place in order to convert this knowledge into company growth. 

Moreover, in 2018 the company had no debt at all and haven’t for some time. This is encouraging for investors as the company is generating enough revenue to cover expenditure whilst still maintaining growth. This means that expansion is stable and is a good indicator that growth will continue in the long term.  

Though the stock looks expensive at first glance, once you have a deeper look you start to understand why. With solid valuation metrics and a dominant market place, the future looks bright for Bioventix and I would expect them to continue to grow moving forward. 

Comments

Post a Comment

Popular posts from this blog

Burford Capital Ltd (BUR)

-
Image
Burford Capital Ltd (BUR) is one stock that I’m still unsure about as it’s very difficult to understand how the business is doing, and therefore understanding its long term profitability proves a problematic task. To give context, Burford Capital is listed on the FTSE AIM 100 and is an investment firm that specialises in generating finances for litigation, along with associated activities such as advisory services in the legal field. WOODFORD Though the stock isn’t in the LF Woodford Equity Income fund, it is held in another Woodford Investment fund, Woodford Patient Capital Trust. This is a closed-ended fund, aimed at delivering long term growth. However, due to being under the same management in Woodford, the firm could suffer indirectly from a decrease in sentiment towards Woodford’s investment approach. VOLATILE The business has done extremely well in the long term, recording a return of 691% since 2016. However, the stock has been particularly volatile in the sh
Read more

Platform Capitalism

-
Image
The growing emergence of digital platforms has seen the rise of companies such as Alphabet (Google), Uber and Deliveroo grow to global dominance. These companies are becoming ever prominent in society, highlighted by how ordinary terms have been replaced by brand equivalents such as to search the web is now ‘to Google it’ and ordering takeaway is now ‘I’ll get a Deliveroo’. These companies are disrupting the global economic market through technology-driven innovation, in which investment opportunities are rife. In this blog I look at the founding concepts of these companies through Srnicek’s work on platform capitalism and how this has presented investment opportunities within the different types of platforms.  PLATFORMS All companies mentioned are built on digital platforms, which monopolise and utilise data. For example, Google uses vast data amassed from Internet users and analyses it to produce highly segmented audiences that are more valuable to advertisers. As such, Google
Read more

Switching lanes: the electric vehicle market

-
Image
Transport is integral to our everyday lives as it allows us to get to work, visit friends and explore new places. As a result, it presents an interesting sector full of attractive investment opportunities. In this article, I look at how the electric vehicle (EV) market is driving transition in the automotive industry, presenting a new source of growth as fossil fuel vehicles are phased out as we move towards a low-carbon economy. Key geographical players currently dominate the EV market include German BMW and Volkswagen, US-based Tesla, BYD in China and Japanese Nissan. These companies are making progressive developments with Tesla launching earlier this year its Model Y, an electric seven passenger vehicle and more recently its Cybertruck. With global supply chains, these companies can efficiently tap into the global EV market. Nissan for example have pushed their Nissan Leaf into the Indonesia market last year, with the Philippines market in the pipeline for later this year.
Read more